{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:13:25Z","timestamp":1790018005016,"version":"4.0.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00787-020-01542-3","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T14:02:31Z","timestamp":1588946551000},"page":"1485-1501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders"],"prefix":"10.1007","volume":"30","author":[{"given":"Susan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany S.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2044-1538","authenticated-orcid":false,"given":"Timothy R.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"1542_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpeds.2018.09.021","volume":"206","author":"RM Ghandour","year":"2019","unstructured":"Ghandour RM, Sherman LJ, Vladutiu CJ, Ali MM, Lynch SE, Bitsko RH et al (2019) Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr 206:256\u2013267","journal-title":"J Pediatr"},{"key":"1542_CR2","unstructured":"National Institute of Mental Health (2019) Mental Health Information, Statistics, Major Depression"},{"issue":"10","key":"1542_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00787-013-0411-0","volume":"22","author":"EA Bertha","year":"2013","unstructured":"Bertha EA, Bal\u00e1zs J (2013) Subthreshold depression in adolescence: a systematic review. Eur Child Adolesc Psychiatry [Internet] 22(10):589\u2013603","journal-title":"Eur Child Adolesc Psychiatry [Internet]"},{"issue":"5","key":"1542_CR4","first-page":"442","volume":"86","author":"MS Clark","year":"2012","unstructured":"Clark MS, Jansen KL, Cloy JA (2012) Treatment of childhood and adolescent depression. Am Fam Physician [Internet] 86(5):442\u2013448","journal-title":"Am Fam Physician [Internet]"},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.chi.0000242228.75516.21","volume":"45","author":"B Kennard","year":"2006","unstructured":"Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A et al (2006) Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1404\u20131411","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jama.292.7.807","volume":"292","author":"JS March","year":"2004","unstructured":"March JS (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for Adolescents with Depression Study (TADS) randomized controlled trial. J Am Med Assoc 292:807\u2013820","journal-title":"J Am Med Assoc"},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jama.299.8.901","volume":"299","author":"D Brent","year":"2008","unstructured":"Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M et al (2008) Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA J Am Med Assoc 299:901\u2013913","journal-title":"JAMA J Am Med Assoc"},{"issue":"7","key":"1542_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1176\/appi.ajp.2010.09040552","volume":"167","author":"GJ Emslie","year":"2010","unstructured":"Emslie GJ, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD et al (2010) Treatment of resistant depression in adolescents (TORDIA): week 24 outcomes. Am J Psychiatry [Internet] 167(7):782\u2013791","journal-title":"Am J Psychiatry [Internet]"},{"key":"1542_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4088\/JCP.09m05885blu","volume":"72","author":"B Vitiello","year":"2011","unstructured":"Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB et al (2011) Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry 72:388\u2013396","journal-title":"J Clin Psychiatry"},{"key":"1542_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/070674370705200108","volume":"52","author":"MT Berlim","year":"2007","unstructured":"Berlim MT, Turecki G (2007) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry. 52:46\u201354","journal-title":"Can J Psychiatry."},{"issue":"1\u20132","key":"1542_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","volume":"9","author":"D Souery","year":"1999","unstructured":"Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O et al (1999) Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol [Internet] 9(1\u20132):83\u201391","journal-title":"Eur Neuropsychopharmacol [Internet]"},{"issue":"11","key":"1542_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.euroneuro.2007.03.009","volume":"17","author":"MT Berlim","year":"2007","unstructured":"Berlim MT, Turecki G (2007) What is the meaning of treatment resistant\/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol [Internet] 17(11):696\u2013707","journal-title":"Eur Neuropsychopharmacol [Internet]"},{"issue":"5","key":"1542_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.9740\/mhc.n207177","volume":"4","author":"A Werremeyer","year":"2014","unstructured":"Werremeyer A (2014) Treatment-resistant depression. Ment Health Clin [Internet] 4(5):211\u2013211","journal-title":"Ment Health Clin [Internet]"},{"issue":"11","key":"1542_CR14","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/chi.0b013e318145ae1c","volume":"46","author":"B Birmaher","year":"2007","unstructured":"Birmaher B, Brent D (2007) Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry [Internet] 46(11):1503\u20131526","journal-title":"J Am Acad Child Adolesc Psychiatry [Internet]"},{"issue":"17","key":"1542_CR15","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1056\/NEJMra050730","volume":"353","author":"JJ Mann","year":"2005","unstructured":"Mann JJ (2005) The medical management of depression. N Engl J Med [Internet] 353(17):1819\u20131834","journal-title":"N Engl J Med [Internet]"},{"issue":"6","key":"1542_CR16","first-page":"797","volume":"53","author":"K Iiunma","year":"1977","unstructured":"Iiunma K, Arakawa Y, Takagi A, Kurata K, Ogihara T (1977) A simplified radioimmunoassay for serum aldosterone\u2013non-extraction method with 125I-labeled aldosterone (author\u2019s transl). Nihon Naibunpi Gakkai Zasshi [Internet] 53(6):797\u2013809","journal-title":"Nihon Naibunpi Gakkai Zasshi [Internet]"},{"issue":"1","key":"1542_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00004583-200301000-00007","volume":"42","author":"A Braconnier","year":"2003","unstructured":"Braconnier A, Le Coent R, Cohen D, DEROXADO Study Group (2003) Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. J Am Acad Child Adolesc Psychiatry [Internet] 42(1):22\u201329","journal-title":"J Am Acad Child Adolesc Psychiatry [Internet]"},{"issue":"6","key":"1542_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/cap.2011.0015","volume":"21","author":"L Maayan","year":"2011","unstructured":"Maayan L, Correll CU (2011) Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol [Internet] 21(6):517\u2013535","journal-title":"J Child Adolesc Psychopharmacol [Internet]"},{"key":"1542_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/cap.1996.6.259","volume":"6","author":"N Ghaziuddin","year":"1996","unstructured":"Ghaziuddin N, King CA, Naylor MW, Ghaziuddin M, Chaudhary N, Giordani B et al (1996) Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression. J Child Adolesc Psychopharmacol 6:259\u2013271","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"1542_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00787-010-0155-z","volume":"20","author":"LE Wachtel","year":"2011","unstructured":"Wachtel LE, Jaffe R, Kellner CH (2011) Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy. Eur Child Adolesc Psychiatry [Internet] 20(3):147\u2013152","journal-title":"Eur Child Adolesc Psychiatry [Internet]"},{"key":"1542_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1089\/cap.2015.0139","volume":"26","author":"CC Puffer","year":"2016","unstructured":"Puffer CC, Wall CA, Huxsahl JE, Frye MA (2016) A 20 year practice review of electroconvulsive therapy for adolescents. J Child Adolesc Psychopharmacol 26:632\u2013636","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1542_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00124509-200203000-00012","volume":"18","author":"G Walter","year":"2002","unstructured":"Walter G, McDonald A, Rey JM, Rosen A (2002) Medical student knowledge and attitudes regarding ECT prior to and after viewing ECT scenes from movies. J ECT 18:43\u201346","journal-title":"J ECT"},{"key":"1542_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0165-1781(01)00299-2","volume":"104","author":"O Taieb","year":"2001","unstructured":"Taieb O, Flament M, Corcos M, Jeammet P, Basquin M, Mazet P et al (2001) Electroconvulsive therapy in adolescents with mood disorder: patients\u2019 and parents\u2019 attitudes. Psychiatry Res 104:183\u2013190","journal-title":"Psychiatry Res"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/YCT.0b013e3181dd17eb","volume":"26","author":"PE Croarkin","year":"2010","unstructured":"Croarkin PE, Wall CA, McClintock SM, Kozel FA, Husain MM, Sampson SM (2010) The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT 26:323\u2013329","journal-title":"J ECT"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/YCT.0b013e318156aa49","volume":"24","author":"Y Bloch","year":"2008","unstructured":"Bloch Y, Grisaru N, Harel EV, Beitler G, Faivel N, Ratzoni G et al (2008) Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT 24:156\u2013159","journal-title":"J ECT"},{"key":"1542_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fpsyt.2019.00170","volume":"10","author":"FP MacMaster","year":"2019","unstructured":"MacMaster FP, Croarkin PE, Wilkes TC, McLellan Q, Langevin LM, Jaworska N et al (2019) Repetitive transcranial magnetic stimulation in youth with treatment resistant major depression. Front Psychiatry [Internet] 10:170","journal-title":"Front Psychiatry [Internet]"},{"issue":"8","key":"1542_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/archpedi.158.8.760","volume":"158","author":"G Saluja","year":"2004","unstructured":"Saluja G, Iachan R, Scheidt PC, Overpeck MD, Sun W, Giedd JN (2004) Prevalence of and risk factors for depressive symptoms among young adolescents. Arch Pediatr Adolesc Med [Internet] 158(8):760\u2013765","journal-title":"Arch Pediatr Adolesc Med [Internet]"},{"key":"1542_CR28","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/00004583-199611000-00011","volume":"35","author":"B Birmaher","year":"1996","unstructured":"Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE et al (1996) Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 35:1427\u20131439","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/00004583-199611000-00011","volume":"35","author":"B Birmaher","year":"1996","unstructured":"Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J (1996) Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 35:1427\u20131439","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archpsyc.59.3.225","volume":"59","author":"DM Fergusson","year":"2002","unstructured":"Fergusson DM, Woodward LJ (2002) Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry 59:225\u2013231","journal-title":"Arch Gen Psychiatry"},{"key":"1542_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4088\/JCP.08m04607","volume":"70","author":"B Vitiello","year":"2009","unstructured":"Vitiello B, Silva SG, Rohde P, Kratochvil CJ, Kennard BD, Reinecke MA et al (2009) Suicidal events in the treatment for adolescents with depression study (TADS). J Clin Psychiatry 70:741\u2013747","journal-title":"J Clin Psychiatry"},{"key":"1542_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cpt196563279","volume":"6","author":"EF Domino","year":"1965","unstructured":"Domino EF, Chodoff P, Corsenn G (1965) Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther [Internet] 6:279\u2013291","journal-title":"Clin Pharmacol Ther [Internet]"},{"issue":"2","key":"1542_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF03011442","volume":"36","author":"DL Reich","year":"1989","unstructured":"Reich DL, Silvay G (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth [Internet] 36(2):186\u2013197","journal-title":"Can J Anaesth [Internet]"},{"key":"1542_CR34","unstructured":"United States Food and Drug Administration (1970) Ketalar NDA 016812 [Internet]. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=016812 (cited 7 Sep 2019)"},{"issue":"3","key":"1542_CR35","first-page":"452","volume":"50","author":"MS Sadove","year":"1971","unstructured":"Sadove MS, Shulman M, Hatano S, Fevold N (1971) Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg [Internet] 50(3):452\u2013457","journal-title":"Anesth Analg [Internet]"},{"issue":"5","key":"1542_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1067\/mcp.2001.119722","volume":"70","author":"H Ihmsen","year":"2001","unstructured":"Ihmsen H, Geisslinger G, Sch\u00fcttler J (2001) Stereoselective pharmacokinetics of ketamine: R(\u2212)-ketamine inhibits the elimination of S(+)-ketamine. Clin Pharmacol Ther [Internet] 70(5):431\u2013438","journal-title":"Clin Pharmacol Ther [Internet]"},{"key":"1542_CR37","first-page":"612","volume":"10","author":"L Li","year":"2016","unstructured":"Li L, Vlisides PE (2016) Ketamine: 50 years of modulating the mind. Front Hum Neurosci [Internet] 10:612","journal-title":"Front Hum Neurosci [Internet]"},{"issue":"14","key":"1542_CR38","first-page":"791","volume":"284","author":"CE Reier","year":"1971","unstructured":"Reier CE (1971) Ketamine\u2014\"dissociative agent\" or hallucinogen? N Engl J Med [Internet] 284(14):791\u2013792","journal-title":"N Engl J Med [Internet]"},{"issue":"4","key":"1542_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/02791072.2000.10400244","volume":"32","author":"KL Jansen","year":"2000","unstructured":"Jansen KL (2000) A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drugs [Internet] 32(4):419\u2013433","journal-title":"J Psychoactive Drugs [Internet]"},{"issue":"4","key":"1542_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry [Internet] 47(4):351\u2013354","journal-title":"Biol Psychiatry [Internet]"},{"key":"1542_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al (2006) A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"1542_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","volume":"72","author":"M Aan Het Rot","year":"2012","unstructured":"Aan Het Rot M, Zarate CA, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry [Internet] 72(7):537\u2013547","journal-title":"Biol Psychiatry [Internet]"},{"issue":"4","key":"1542_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"G Sanacora","year":"2017","unstructured":"Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF et al (2017) A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry [Internet] 74(4):399\u2013405","journal-title":"JAMA Psychiatry [Internet]"},{"issue":"9","key":"1542_CR44","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI (2016) Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet [Internet] 55(9):1059\u20131077","journal-title":"Clin Pharmacokinet [Internet]"},{"issue":"3","key":"1542_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2045125316631267","volume":"6","author":"J Muller","year":"2016","unstructured":"Muller J, Pentyala S, Dilger J, Pentyala S (2016) Ketamine enantiomers in the rapid and sustained antidepressant effects. Ther Adv Psychopharmacol [Internet] 6(3):185\u2013192","journal-title":"Ther Adv Psychopharmacol [Internet]"},{"issue":"1\u20133","key":"1542_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","volume":"698","author":"R Moaddel","year":"2013","unstructured":"Moaddel R, Abdrakhmanova G, Kozak J, Jozwiak K, Toll L, Jimenez L et al (2013) Sub-anesthetic concentrations of (R, S)-ketamine metabolites inhibit acetylcholine-evoked currents in \u03b17 nicotinic acetylcholine receptors. Eur J Pharmacol [Internet] 698(1\u20133):228\u2013234","journal-title":"Eur J Pharmacol [Internet]"},{"issue":"1","key":"1542_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0014-2999(92)90248-3","volume":"213","author":"HU Zeilhofer","year":"1992","unstructured":"Zeilhofer HU, Swandulla D, Geisslinger G, Brune K (1992) Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol [Internet] 213(1):155\u2013158","journal-title":"Eur J Pharmacol [Internet]"},{"key":"1542_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","volume":"181","author":"L Chang","year":"2019","unstructured":"Chang L, Zhang K, Pu Y, Qu Y, Wang S-M, Xiong Z et al (2019) Comparison of antidepressant and side effects in mice after intranasal administration of (R, S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacol Biochem Behav [Internet] 181:53\u201359","journal-title":"Pharmacol Biochem Behav [Internet]"},{"issue":"1","key":"1542_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.116.239228","volume":"361","author":"K Fukumoto","year":"2017","unstructured":"Fukumoto K, Toki H, Iijima M, Hashihayata T, Yamaguchi J-I, Hashimoto K et al (2017) Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine. J Pharmacol Exp Ther [Internet] 361(1):9\u201316","journal-title":"J Pharmacol Exp Ther [Internet]"},{"key":"1542_CR50","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang J, Ren Q, Yao W, Ma M et al (2015) R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry [Internet] 5:e632","journal-title":"Transl Psychiatry [Internet]"},{"key":"1542_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","volume":"116","author":"J-C Zhang","year":"2014","unstructured":"Zhang J-C, Li S-X, Hashimoto K (2014) R (\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine. Pharmacol Biochem Behav [Internet] 116:137\u2013141","journal-title":"Pharmacol Biochem Behav [Internet]"},{"issue":"12","key":"1542_CR52","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s002280100353","volume":"57","author":"J Persson","year":"2002","unstructured":"Persson J, Hasselstr\u00f6m J, Maurset A, Oye I, Svensson JO, Almqvist O et al (2002) Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity. Eur J Clin Pharmacol [Internet] 57(12):869\u2013875","journal-title":"Eur J Clin Pharmacol [Internet]"},{"key":"1542_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-020-01110-5","author":"GC Leal","year":"2020","unstructured":"Leal GC, Bandeira ID, Correia-Melo FS, Telles M, Mello RP, Vieira F et al (2020) Intravenous arketamine for treatment-resistant depression: open-label pilot study. Eur Arch Psychiatry Clin Neurosci [Internet]. https:\/\/doi.org\/10.1007\/s00406-020-01110-5","journal-title":"Eur Arch Psychiatry Clin Neurosci [Internet]"},{"issue":"38","key":"1542_CR54","doi-asserted-by":"publisher","first-page":"e12414","DOI":"10.1097\/MD.0000000000012414","volume":"97","author":"FS Correia-Melo","year":"2018","unstructured":"Correia-Melo FS, Leal GC, Carvalho MS, Jesus-Nunes AP, Ferreira CBN, Vieira F et al (2018) Comparative study of esketamine and racemic ketamine in treatment-resistant depression: protocol for a non-inferiority clinical trial. Medicine (Baltimore) [Internet] 97(38):e12414","journal-title":"Medicine (Baltimore) [Internet]"},{"key":"1542_CR55","unstructured":"United States Food and Drug Administration (2019) United States Food and Drug Administration: FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor\u2019s office or clinic [Internet]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified (cited 18 Jan 2020)"},{"issue":"3","key":"1542_CR56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1542\/peds.2013-4060","volume":"133","author":"DA Frattarelli","year":"2014","unstructured":"Frattarelli DA, Galinkin JL, Green TP, Johnson TD, Neville KA, Paul IM et al (2014) Off-label use of drugs in children. Pediatrics [Internet] 133(3):563\u2013567. https:\/\/doi.org\/10.1542\/peds.2013-4060","journal-title":"Pediatrics [Internet]"},{"key":"1542_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev [Internet] 4:1","journal-title":"Syst Rev [Internet]"},{"key":"1542_CR58","unstructured":"Veritas Health Innovation. Covidence systematic review software [Internet]. Veritas Health Innovation (cited 18 Jan 2020)"},{"key":"1542_CR59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry [Internet] 134:382\u2013389","journal-title":"Br J Psychiatry [Internet]"},{"issue":"4","key":"1542_CR60","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1542\/peds.64.4.442","volume":"64","author":"EO Poznanski","year":"1979","unstructured":"Poznanski EO, Cook SC, Carroll BJ (1979) A depression rating scale for children. Pediatrics [Internet] 64(4):442\u2013450","journal-title":"Pediatrics [Internet]"},{"key":"1542_CR61","unstructured":"Poznanski EO, Mokros HB (1996) Children\u2019s Depression Rating Scale, Revised (CDRS-R), Los Angeles"},{"issue":"1\u20133","key":"1542_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jad.2006.03.026","volume":"95","author":"D Papolos","year":"2006","unstructured":"Papolos D, Hennen J, Cockerham MS, Thode HC, Youngstrom EA (2006) The child bipolar questionnaire: a dimensional approach to screening for pediatric bipolar disorder. J Affect Disord [Internet] 95(1\u20133):149\u2013158","journal-title":"J Affect Disord [Internet]"},{"key":"1542_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1176\/ajp.143.5.670-a","volume":"143","author":"SC Yudofsky","year":"1986","unstructured":"Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D (1986) The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35\u201339","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1542_CR64","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.janxdis.2006.01.006","volume":"20","author":"EA Storch","year":"2006","unstructured":"Storch EA, Murphy TK, Adkins JW, Lewin AB, Geffken GR, Johns NB et al (2006) The children\u2019s Yale\u2013Brown obsessive\u2013compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord [Internet] 20(8):1055\u20131070","journal-title":"J Anxiety Disord [Internet]"},{"issue":"2","key":"1542_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","volume":"47","author":"AT Beck","year":"1979","unstructured":"Beck AT, Kovacs M, Weissman A (1979) Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol [Internet] 47(2):343\u2013352","journal-title":"J Consult Clin Psychol [Internet]"},{"issue":"1","key":"1542_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1024465317902","volume":"11","author":"JD Bremner","year":"1998","unstructured":"Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS et al (1998) Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress [Internet] 11(1):125\u2013136","journal-title":"J Trauma Stress [Internet]"},{"issue":"7","key":"1542_CR67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/cap.2018.0030","volume":"28","author":"KR Cullen","year":"2018","unstructured":"Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y et al (2018) Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study. J Child Adolesc Psychopharmacol [Internet] 28(7):437\u2013444","journal-title":"J Child Adolesc Psychopharmacol [Internet]"},{"issue":"1\u20133","key":"1542_CR68","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jad.2012.08.040","volume":"147","author":"DF Papolos","year":"2013","unstructured":"Papolos DF, Teicher MH, Faedda GL, Murphy P, Mattis S (2013) Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder\/fear of harm phenotype. J Affect Disord [Internet] 147(1\u20133):431\u2013436","journal-title":"J Affect Disord [Internet]"},{"key":"1542_CR69","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/cap.2019.0028","volume":"29","author":"P Zarrinnegar","year":"2019","unstructured":"Zarrinnegar P, Kothari J, Cheng K (2019) Successful use of ketamine for the treatment of psychotic depression in a teenager. J Child Adolesc Psychopharmacol [Internet] 29:472\u2013473","journal-title":"J Child Adolesc Psychopharmacol [Internet]"},{"issue":"4","key":"1542_CR70","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jaac.2017.01.006","volume":"56","author":"JB Dwyer","year":"2017","unstructured":"Dwyer JB, Beyer C, Wilkinson ST, Ostroff RB, Qayyum Z, Bloch MH (2017) Ketamine as a treatment for adolescent depression: a case report. J Am Acad Child Adolesc Psychiatry [Internet] 56(4):352\u2013354","journal-title":"J Am Acad Child Adolesc Psychiatry [Internet]"},{"issue":"4","key":"1542_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0022-0736(97)80046-5","volume":"30","author":"A Castellanos","year":"1997","unstructured":"Castellanos A, Moleiro F, Guerrero J, Awaad MI, Myerburg RJ (1997) Intermittent parasystole with exit block. J Electrocardiol [Internet] 30(4):331\u2013335","journal-title":"J Electrocardiol [Internet]"},{"issue":"3","key":"1542_CR72","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1542\/peds.2014-4152","volume":"136","author":"AC Donoghue","year":"2015","unstructured":"Donoghue AC, Roback MG, Cullen KR (2015) Remission from behavioral dysregulation in a child with PTSD after receiving procedural ketamine. Pediatrics [Internet] 136(3):e694\u2013e696. https:\/\/doi.org\/10.1542\/peds.2014-4152","journal-title":"Pediatrics [Internet]"},{"key":"1542_CR73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jad.2017.08.081","volume":"225","author":"D Papolos","year":"2018","unstructured":"Papolos D, Frei M, Rossignol D, Mattis S, Hernandez-Garcia LC, Teicher MH (2018) Clinical experience using intranasal ketamine in the longitudinal treatment of juvenile bipolar disorder with fear of harm phenotype. J Affect Disord [Internet] 225:545\u2013551","journal-title":"J Affect Disord [Internet]"},{"key":"1542_CR74","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Revision 4th edition with text, editor. American Psychiatric Press, Washington, DC, pp 1\u20132"},{"key":"1542_CR75","unstructured":"Beck AT (1988) Beck Hopelessness Scale, San Antonio"},{"key":"1542_CR76","first-page":"9375910","volume":"2018","author":"G Weber","year":"2018","unstructured":"Weber G, Yao J, Binns S, Namkoong S (2018) Case report of subanesthetic intravenous ketamine infusion for the treatment of neuropathic pain and depression with suicidal features in a pediatric patient. Case Rep Anesthesiol [Internet] 2018:9375910","journal-title":"Case Rep Anesthesiol [Internet]"},{"key":"1542_CR77","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. U.S. Government Printing Office, Rockville"},{"issue":"5","key":"1542_CR78","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2214\/AJR.08.1743","volume":"192","author":"KP Mason","year":"2009","unstructured":"Mason KP, Padua H, Fontaine PJ, Zurakowski D (2009) Radiologist-supervised ketamine sedation for solid organ biopsies in children and adolescents. AJR Am J Roentgenol [Internet] 192(5):1261\u20131265","journal-title":"AJR Am J Roentgenol [Internet]"},{"key":"1542_CR79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12887-015-0515-4","volume":"15","author":"KA Sheehy","year":"2015","unstructured":"Sheehy KA, Muller EA, Lippold C, Nouraie M, Finkel JC, Quezado ZMN (2015) Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study. BMC Pediatr [Internet] 15:198","journal-title":"BMC Pediatr [Internet]"},{"issue":"10","key":"1542_CR80","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/aas.12571","volume":"59","author":"R Minoshima","year":"2015","unstructured":"Minoshima R, Kosugi S, Nishimura D, Ihara N, Seki H, Yamada T et al (2015) Intra- and postoperative low-dose ketamine for adolescent idiopathic scoliosis surgery: a randomized controlled trial. Acta Anaesthesiol Scand [Internet] 59(10):1260\u20131268","journal-title":"Acta Anaesthesiol Scand [Internet]"},{"issue":"2","key":"1542_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/AJP.0b013e3181b511ab","volume":"26","author":"WT Zempsky","year":"2010","unstructured":"Zempsky WT, Loiselle KA, Corsi JM, Hagstrom JN (2010) Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series. Clin J Pain [Internet] 26(2):163\u2013167","journal-title":"Clin J Pain [Internet]"},{"issue":"6","key":"1542_CR82","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jpain.2007.02.429","volume":"8","author":"JC Finkel","year":"2007","unstructured":"Finkel JC, Pestieau SR, Quezado ZMN (2007) Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain [Internet] 8(6):515\u2013521","journal-title":"J Pain [Internet]"},{"issue":"1","key":"1542_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.annemergmed.2005.02.024","volume":"46","author":"JY Allen","year":"2005","unstructured":"Allen JY, Macias CG (2005) The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med [Internet] 46(1):43\u201350","journal-title":"Ann Emerg Med [Internet]"},{"issue":"10","key":"1542_CR84","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/adc.48.10.757","volume":"48","author":"J Dobbing","year":"1973","unstructured":"Dobbing J, Sands J (1973) Quantitative growth and development of human brain. Arch Dis Child [Internet] 48(10):757\u2013767","journal-title":"Arch Dis Child [Internet]"},{"issue":"1","key":"1542_CR85","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0378-3782(79)90022-7","volume":"3","author":"J Dobbing","year":"1979","unstructured":"Dobbing J, Sands J (1979) Comparative aspects of the brain growth spurt. Early Hum Dev [Internet] 3(1):79\u201383","journal-title":"Early Hum Dev [Internet]"},{"issue":"9","key":"1542_CR86","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1046\/j.1460-9592.2002.00883.x","volume":"12","author":"H Hayashi","year":"2002","unstructured":"Hayashi H, Dikkes P, Soriano SG (2002) Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth [Internet] 12(9):770\u2013774","journal-title":"Paediatr Anaesth [Internet]"},{"issue":"4","key":"1542_CR87","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0006-2952(01)00696-7","volume":"62","author":"C Ikonomidou","year":"2001","unstructured":"Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, Felderhoff-Mueser U et al (2001) Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol [Internet] 62(4):401\u2013405","journal-title":"Biochem Pharmacol [Internet]"},{"issue":"1","key":"1542_CR88","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/157015911795017155","volume":"9","author":"F Liu","year":"2011","unstructured":"Liu F, Paule MG, Ali S, Wang C (2011) Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol [Internet] 9(1):256\u2013261","journal-title":"Curr Neuropharmacol [Internet]"},{"key":"1542_CR89","first-page":"6871089","volume":"2017","author":"W Liu","year":"2017","unstructured":"Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W et al (2017) The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast [Internet] 2017:6871089","journal-title":"Neural Plast [Internet]"},{"issue":"6","key":"1542_CR90","doi-asserted-by":"publisher","first-page":"e99855","DOI":"10.1371\/journal.pone.0099855","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Zhou M, Wang X, Yang X, Wang M, Zhang C et al (2014) Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats. PLoS One [Internet] 9(6):e99855","journal-title":"PLoS One [Internet]"},{"issue":"2","key":"1542_CR91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ANA.0000000000000027","volume":"26","author":"J Yan","year":"2014","unstructured":"Yan J, Jiang H (2014) Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain. J Neurosurg Anesthesiol [Internet] 26(2):155\u2013160","journal-title":"J Neurosurg Anesthesiol [Internet]"},{"key":"1542_CR92","doi-asserted-by":"publisher","first-page":"111928","DOI":"10.1016\/j.bbr.2019.111928","volume":"369","author":"MLS Bates","year":"2019","unstructured":"Bates MLS, Trujillo KA (2019) Long-lasting effects of repeated ketamine administration in adult and adolescent rats. Behav Brain Res [Internet] 369:111928","journal-title":"Behav Brain Res [Internet]"},{"key":"1542_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jchemneu.2018.12.002","volume":"96","author":"AY Onaolapo","year":"2019","unstructured":"Onaolapo AY, Ayeni OJ, Ogundeji MO, Ajao A, Onaolapo OJ, Owolabi AR (2019) Subchronic ketamine alters behaviour, metabolic indices and brain morphology in adolescent rats: involvement of oxidative stress, glutamate toxicity and caspase-3-mediated apoptosis. J Chem Neuroanat [Internet] 96:22\u201333","journal-title":"J Chem Neuroanat [Internet]"},{"issue":"7","key":"1542_CR94","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1124\/dmd.30.7.853","volume":"30","author":"Y Hijazi","year":"2002","unstructured":"Hijazi Y, Boulieu R (2002) Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos [Internet] 30(7):853\u2013858","journal-title":"Drug Metab Dispos [Internet]"},{"issue":"6","key":"1542_CR95","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425255.2.6.875","volume":"2","author":"M Martignoni","year":"2006","unstructured":"Martignoni M, Groothuis GMM, de Kanter R (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol [Internet] 2(6):875\u2013894","journal-title":"Expert Opin Drug Metab Toxicol [Internet]"},{"issue":"10","key":"1542_CR96","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.biopsych.2013.04.027","volume":"74","author":"EM Parise","year":"2013","unstructured":"Parise EM, Alcantara LF, Warren BL, Wright KN, Hadad R, Sial OK et al (2013) Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats. Biol Psychiatry [Internet] 74(10):750\u2013759","journal-title":"Biol Psychiatry [Internet]"},{"issue":"10","key":"1542_CR97","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00787-012-0292-7","volume":"21","author":"K-H Lee","year":"2012","unstructured":"Lee K-H, Yeh Y-C, Yang P-C, Lin H-C, Wang P-W, Liu T-L et al (2012) Individual and peer factors associated with ketamine use among adolescents in Taiwan. Eur Child Adolesc Psychiatry [Internet] 21(10):553\u2013558","journal-title":"Eur Child Adolesc Psychiatry [Internet]"},{"key":"1542_CR98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fnsyn.2018.00039","volume":"10","author":"RD Shepard","year":"2018","unstructured":"Shepard RD, Langlois LD, Browne CA, Berenji A, Lucki I, Nugent FS (2018) Ketamine reverses lateral habenula neuronal dysfunction and behavioral immobility in the forced swim test following maternal deprivation in late adolescent rats. Front Synaptic Neurosci [Internet] 10:39","journal-title":"Front Synaptic Neurosci [Internet]"},{"key":"1542_CR99","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","volume":"156","author":"M Naughton","year":"2014","unstructured":"Naughton M, Clarke G, O\u2019Leary OF, Cryan JF, Dinan TG (2014) A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. J Affect Disord [Internet] 156:24\u201335","journal-title":"J Affect Disord [Internet]"},{"issue":"8","key":"1542_CR100","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/da.22501","volume":"33","author":"CG Abdallah","year":"2016","unstructured":"Abdallah CG, Adams TG, Kelmendi B, Esterlis I, Sanacora G, Krystal JH (2016) Ketamine\u2019s mechanism of action: a path to rapid-acting antidepressants. Depress Anxiety [Internet] 33(8):689\u2013697","journal-title":"Depress Anxiety [Internet]"},{"issue":"10","key":"1542_CR101","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.drudis.2019.07.007","volume":"24","author":"C Kraus","year":"2019","unstructured":"Kraus C, Wasserman D, Henter ID, Acevedo-Diaz E, Kadriu B, Zarate CA (2019) The influence of ketamine on drug discovery in depression. Drug Discov Today [Internet] 24(10):2033\u20132043","journal-title":"Drug Discov Today [Internet]"},{"issue":"3","key":"1542_CR102","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/2013.jamapsychiatry.24","volume":"70","author":"PE Croarkin","year":"2013","unstructured":"Croarkin PE, Nakonezny PA, Husain MM, Melton T, Buyukdura JS, Kennard BD et al (2013) Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry [Internet] 70(3):291\u2013299","journal-title":"JAMA Psychiatry [Internet]"},{"issue":"2","key":"1542_CR103","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1461145713001119","volume":"17","author":"CN Haile","year":"2014","unstructured":"Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A et al (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol [Internet] 17(2):331\u2013336","journal-title":"Int J Neuropsychopharmacol [Internet]"},{"issue":"8","key":"1542_CR104","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1017\/S1461145708009000","volume":"11","author":"GN Pandey","year":"2008","unstructured":"Pandey GN, Ren X, Rizavi HS, Conley RR, Roberts RC, Dwivedi Y (2008) Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol [Internet] 11(8):1047\u20131061","journal-title":"Int J Neuropsychopharmacol [Internet]"},{"issue":"4","key":"1542_CR105","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.pnpbp.2010.03.003","volume":"34","author":"GN Pandey","year":"2010","unstructured":"Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Zhang H, Pavuluri MN (2010) Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog Neuropsychopharmacol Biol Psychiatry [Internet] 34(4):645\u2013651","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry [Internet]"},{"issue":"9","key":"1542_CR106","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/CHI.0b013e31817eecd9","volume":"47","author":"GN Pandey","year":"2008","unstructured":"Pandey GN, Rizavi HS, Dwivedi Y, Pavuluri MN (2008) Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response. J Am Acad Child Adolesc Psychiatry [Internet] 47(9):1077\u20131085","journal-title":"J Am Acad Child Adolesc Psychiatry [Internet]"},{"key":"1542_CR107","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2014.03.026","volume":"1562","author":"F Pacheco D da","year":"2014","unstructured":"Pacheco D da F, Romero TRL, Duarte IDG (2014) Central antinociception induced by ketamine is mediated by endogenous opioids and \u03bc- and \u03b4-opioid receptors. Brain Res [Internet] 1562:69\u201375","journal-title":"Brain Res [Internet]"},{"issue":"12","key":"1542_CR108","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","volume":"175","author":"NR Williams","year":"2018","unstructured":"Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H et al (2018) Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry [Internet] 175(12):1205\u20131215","journal-title":"Am J Psychiatry [Internet]"},{"issue":"4","key":"1542_CR109","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/da.22253","volume":"31","author":"RB Price","year":"2014","unstructured":"Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ et al (2014) Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety [Internet] 31(4):335\u2013343","journal-title":"Depress Anxiety [Internet]"},{"issue":"10","key":"1542_CR110","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM et al (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry [Internet] 170(10):1134\u20131142","journal-title":"Am J Psychiatry [Internet]"},{"key":"1542_CR111","first-page":"CD011612","volume":"9","author":"C Caddy","year":"2015","unstructured":"Caddy C, Amit BH, McCloud TL, Rendell JM, Furukawa TA, McShane R et al (2015) Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev [Internet] 9:CD011612","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"3","key":"1542_CR112","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hup.2475","volume":"30","author":"CM Coyle","year":"2015","unstructured":"Coyle CM, Laws KR (2015) The use of ketamine as an antidepressant: a systematic review and meta-analysis. Hum Psychopharmacol [Internet] 30(3):152\u2013163","journal-title":"Hum Psychopharmacol [Internet]"},{"issue":"1","key":"1542_CR113","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","volume":"5","author":"B Short","year":"2018","unstructured":"Short B, Fong J, Galvez V, Shelker W, Loo CK (2018) Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry [Internet] 5(1):65\u201378","journal-title":"Lancet Psychiatry [Internet]"},{"issue":"6","key":"1542_CR114","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","volume":"71","author":"A Feder","year":"2014","unstructured":"Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S et al (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry [Internet] 71(6):681\u2013688","journal-title":"JAMA Psychiatry [Internet]"},{"key":"1542_CR115","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cct.2018.12.009","volume":"77","author":"SJ Mathew","year":"2019","unstructured":"Mathew SJ, Wilkinson ST, Altinay M, Asghar-Ali A, Chang LC, Collins KA et al (2019) Electroconvulsive therapy (ECT) vs. ketamine in patients with treatment-resistant depression: the ELEKT-D study protocol. Contemp Clin Trials [Internet] 77:19\u201326","journal-title":"Contemp Clin Trials [Internet]"},{"key":"1542_CR116","unstructured":"AACAP Psychopharmacology Committee (2018) AACAP Psychopharmacology Committee Statement on Ketamine"},{"issue":"12","key":"1542_CR117","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","volume":"6","author":"EH Turner","year":"2019","unstructured":"Turner EH (2019) Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval. Lancet Psychiatry [Internet] 6(12):977\u2013979","journal-title":"Lancet Psychiatry [Internet]"},{"issue":"3","key":"1542_CR118","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S2215-0366(19)30533-4","volume":"7","author":"JB Singh","year":"2020","unstructured":"Singh JB, Daly EJ, Mathews M, Fedgchin M, Popova V, Hough D et al (2020) Approval of esketamine for treatment-resistant depression. Lancet Psychiatry [Internet] 7(3):232\u2013235","journal-title":"Lancet Psychiatry [Internet]"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-020-01542-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-020-01542-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-020-01542-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T09:27:24Z","timestamp":1666517244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-020-01542-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":118,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s00787-020-01542-3","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"3 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No statistical consultants were employed in this study. No support for this study was received from any grant, funding source, or commercial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}